Soft robot could aid failing hearts by mimicking healthy cardiac muscles

January 18, 2017

Every year about 2,100 people receive heart transplants in the United States, while 5.7 million suffer from heart failure. Given the scarcity of available donor hearts, clinicians and biomedical engineers from Boston Children's Hospital and Harvard University have spent several years developing a mechanical alternative.

Their proof of concept is reported today in Science Translational Medicine: a soft robotic sleeve that is fitted around the heart, where it twists and compresses the heart's chambers just like healthy cardiac muscle would do.

Heart failure occurs when one or both of the heart's ventricles can no longer collect or pump blood effectively. Ventricular assist devices (VADs) are already used to sustain end-stage heart failure patients awaiting transplant, replacing the work of the ventricles through tubes that take blood out of the heart and push it pumps or rotors that power it into a patient's bloodstream. But while VADs extend lives, they can cause complications.

"I've been implanting VADs in patients for a long time," says Frank Pigula, MD, who took part in the research at Boston Children's Hospital's Heart Center. (He is now chief of pediatric cardiac surgery at Norton Children's Hospital in Louisville, Ky.) "The current generation systems directly expose a patient's blood to artificial materials such as tubing and rotors, which makes necessary the use of blood thinning and anticoagulatory medications that are complication-prone."

These medications allow patients to tolerate VAD implants, but they increase the chance of having a stroke by up to 20 percent. The constant contact between blood and foreign material also carries the inherent risk of serious infection.

Pigula and his collaborators have designed a device that attaches to and snugly hugs the outside of the heart without having any contact with blood. The soft robotic sleeve mimics the heart's natural compression motion using only non-rigid, biocompatible materials.

Their tests -- done in pig hearts given their similar size and structure to human hearts -- show that the device restores acutely failing hearts to 97 percent of their original cardiac output.

"This work represents an exciting proof-of-concept result for this soft robot, demonstrating that it can safely interact with soft tissue and lead to improvements in cardiac function," says Conor Walsh, PhD, the John L. Loeb Associate Professor of Engineering and Applied Sciences at Harvard SEAS and a Core Faculty Member at the Wyss Institute. Walsh, a soft robotics expert, co-led the study with Pigula.

Utilizing pneumatically powered "air muscles," different parts of the device bend and flex via remotely-controlled actuators that initiate the movement, mimicking the orientation of a heart's contracting muscle fibers. One part of the device takes care of the twist, and another, the squeeze.

"The soft robotic actuators are essentially artificial muscles," says Nikolay Vasilyev, MD, a staff scientist in cardiac surgery research at Boston Children's Hospital and co-author on the recent study. "In this sense, the robotic sleeve mimics both ventricles of the heart."

According to Ellen Roche, PhD, the study's first author, other types of cardiac sleeves work against the normal curvature of the heart, only helping with the squeeze but not the twist.

"Very few assist with the overall twisting motion," says Roche, who worked on Walsh's team at Harvard SEAS and the Wyss Institute. She is now a postdoctoral researcher at National University of Ireland Galway.

The soft robotic heart sleeve also contains sophisticated sensing abilities that measure pressure at specific points on the heart's surface.

"We can independently control portions of the device and adjust assistance to a patient's needs," says Roche. "I'm optimistic the soft robotic sleeve could potentially be used for short-term cardiac rehabilitation in addition to long-term therapy."

"The cardiac field had turned away from idea of developing heart compression instead of blood-pumping VADs due to technological limitations," says Pigula. "But now, with advancements in soft robotics, it's time to turn back. Most people with heart failure still have some function left. One day. the robotic sleeve may help their heart work well enough that their quality of life can be restored."
-end-


Boston Children's Hospital

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.